Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia
โ Scribed by Robert Amato; Hagop Kantarjian; Ronald Walters; Michael Keating
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 301 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
A patient with acute promyelocytic leukemia manifested peripheral blastosis with 50% peripheral blasts and an absolute blast count of 10,0o0/pl 2 weeks after the start of induction chemotherapy. The subsequent disappearance of the peripheral and marrow blasts without further chemotherapy was noticed, and complete remission was achieved on day 25 of chemotherapy. The histologic and clinical implications of this phenomenon are discussed.
๐ SIMILAR VOLUMES
## Background: The authors report the occurrence of fatal or near-fatal sepsis in 16 of 38 children with newly diagnosed acute lymphoblastic leukemia (all) treated with a new induction regimen that differed from its predecessor by the substitution of dexamethasone for prednisone. ## Methods: The
## BACKGROUND. Interleukin-2 (IL-2) has immunomodulatory effects, including stimulating the activity of cytotoxic T cells and natural killer cells, and inducing the generation of lymphokine-activated killer cells. The authors investigated whether IL-2 may improve the duration of complete remission